|
humans |
14 |
|
hong kong |
13 |
|
anti-bacterial agents - pharmacology |
12 |
|
microbial sensitivity tests |
12 |
|
carrier state - microbiology |
9 |
|
female |
9 |
|
molecular epidemiology |
9 |
|
plasmids |
9 |
|
streptococcus pneumoniae |
9 |
|
antimicrobial resistance |
8 |
|
child |
8 |
|
child, preschool |
8 |
|
drug resistance |
8 |
|
drug resistance, bacterial |
8 |
|
polymerase chain reaction |
8 |
|
antimicrobial drug resistance |
7 |
|
child day care centers |
7 |
|
enterobacteriaceae |
7 |
|
epidemiology |
7 |
|
male |
7 |
|
nasopharynx - microbiology |
7 |
|
algorithms |
6 |
|
animals |
6 |
|
animals, domestic - microbiology |
6 |
|
bacterial proteins - genetics |
6 |
|
dna, bacterial - chemistry - genetics |
6 |
|
escherichia coli infections - microbiology |
6 |
|
heptavalent pneumococcal conjugate vaccine |
6 |
|
mass vaccination |
6 |
|
pneumococcal infections - microbiology |
6 |
|
pneumococcal vaccines |
6 |
|
prevalence |
6 |
|
sequence analysis, dna |
6 |
|
serotyping |
6 |
|
streptococcus pneumoniae - drug effects - immunology |
6 |
|
time factors |
6 |
|
vaccines, conjugate |
6 |
|
adult |
5 |
|
bacteremia - microbiology |
5 |
|
beta-lactamases - biosynthesis - genetics |
5 |
|
carrier state - epidemiology - microbiology |
5 |
|
cattle |
5 |
|
chicken |
5 |
|
colonization |
5 |
|
ctx-m-14 beta-lactamase |
5 |
|
dendritic cells - immunology - microbiology - virology |
5 |
|
disease outbreaks |
5 |
|
drug resistance, multiple, bacterial - genetics |
5 |
|
escherichia coli - drug effects - genetics - metabolism |
5 |
|
extended-spectrum beta-lactamases |
5 |
|
food microbiology |
5 |
|
genes, bacterial |
5 |
|
hong kong - epidemiology |
5 |
|
influenza a virus, h1n1 subtype - immunology |
5 |
|
influenza, human - immunology |
5 |
|
molecular diagnostic techniques |
5 |
|
nose - microbiology |
5 |
|
pets |
5 |
|
pigs |
5 |
|
plasmid |
5 |
|
pneumococcal infections - immunology |
5 |
|
polymerase chain reaction - methods |
5 |
|
poultry |
5 |
|
rapid diagnosis |
5 |
|
reagent kits, diagnostic |
5 |
|
real-time pcr |
5 |
|
restriction fragment length polymorphism |
5 |
|
reverse transcriptase polymerase chain reaction |
5 |
|
sars coronavirus |
5 |
|
sars virus - genetics - isolation & purification |
5 |
|
sensitivity and specificity |
5 |
|
serotype |
5 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
5 |
|
staphylococcus aureus |
5 |
|
streptococcus pneumoniae - immunology |
5 |
|
swine |
5 |
|
aminoacyltransferases |
4 |
|
antibiotic resistance |
4 |
|
antibiotic sensitivity |
4 |
|
autophagy |
4 |
|
autophagy - genetics - immunology |
4 |
|
bacterium isolate |
4 |
|
beta-lactamases - biosynthesis |
4 |
|
beta-lactamases - genetics |
4 |
|
carrier proteins - genetics |
4 |
|
carrier state |
4 |
|
cephalosporin resistance |
4 |
|
cloaca - microbiology |
4 |
|
conjugation, genetic |
4 |
|
ctx-m-14 β-lactamase |
4 |
|
cystitis - microbiology |
4 |
|
day care centers |
4 |
|
drug resistance, bacterial - genetics |
4 |
|
drug resistance, microbial |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
electrophoresis, gel, pulsed-field |
4 |
|
escherichia coli |
4 |
|
escherichia coli - drug effects - enzymology - isolation & purification |
4 |
|
escherichia coli - enzymology - genetics - isolation & purification |
4 |
|
extended-spectrum β-lactamases |
4 |
|
genotype |
4 |
|
haemophilus influenzae - drug effects |
4 |
|
hexosyltransferases - genetics |
4 |
|
hiv infections - genetics - metabolism |
4 |
|
hiv-1 - pathogenicity |
4 |
|
hiv-1 tat |
4 |
|
hospitals |
4 |
|
infant |
4 |
|
interferon |
4 |
|
interferon-gamma - metabolism |
4 |
|
methicillin-resistant staphylococcus aureus |
4 |
|
methicillin-resistant staphylococcus aureus - classification - drug effects - genetics - isolation and purification |
4 |
|
methicillin-resistant staphylococcus aureus - drug effects - isolation & purification |
4 |
|
molecular sequence data |
4 |
|
mrsa |
4 |
|
multilocus sequence typing |
4 |
|
muramoylpentapeptide carboxypeptidase - genetics |
4 |
|
mutation - genetics - physiology |
4 |
|
nalidixic acid - pharmacology |
4 |
|
ofloxacin - pharmacology |
4 |
|
opportunistic infection |
4 |
|
penicillin resistance - genetics |
4 |
|
penicillin-binding proteins |
4 |
|
peptidyl transferases - genetics |
4 |
|
pneumococcal infections - epidemiology - microbiology |
4 |
|
pneumococcal vaccines - administration and dosage - immunology |
4 |
|
polymorphism, restriction fragment length |
4 |
|
predictive value of tests |
4 |
|
proteus mirabilis - classification - drug effects - enzymology |
4 |
|
rectum - microbiology |
4 |
|
restriction fragment length |
4 |
|
reverse transcriptase polymerase chain reaction - methods |
4 |
|
risk factors |
4 |
|
rodentia - microbiology |
4 |
|
signal transduction - genetics - immunology |
4 |
|
staphylococcal infections - epidemiology - microbiology |
4 |
|
staphylococcal infections - microbiology |
4 |
|
streptococcus pneumoniae - classification - drug effects - isolation and purification |
4 |
|
streptococcus pneumoniae - drug effects |
4 |
|
vancomycin |
4 |
|
vancomycin - pharmacology |
4 |
|
vancomycin resistance |
4 |
|
acyltransferases - genetics - metabolism - toxicity |
3 |
|
aged |
3 |
|
aged, 80 and over |
3 |
|
bacterial proteins |
3 |
|
bacterial toxins - genetics - metabolism - toxicity |
3 |
|
bacterium examination |
3 |
|
beta-lactam resistance |
3 |
|
beta-lactam resistance - genetics |
3 |
|
beta-lactamases |
3 |
|
beta-lactamases - analysis - antagonists & inhibitors |
3 |
|
beta-lactamases - analysis - genetics |
3 |
|
binary toxin |
3 |
|
blood culture |
3 |
|
carbapenemases |
3 |
|
ceftazidime - blood - pharmacology - urine |
3 |
|
ceftriaxone - blood - pharmacology - urine |
3 |
|
cephalosporin resistance - genetics |
3 |
|
cephalosporinase - genetics |
3 |
|
chi-square distribution |
3 |
|
clostridioides difficile |
3 |
|
cluster analysis |
3 |
|
co-trimoxazole |
3 |
|
communicable disease |
3 |
|
cotrimoxazole resistance |
3 |
|
cross infection - epidemiology - microbiology |
3 |
|
ctx-m enzymes |
3 |
|
cystitis - epidemiology - microbiology |
3 |
|
disk diffusion |
3 |
|
dna fingerprinting |
3 |
|
dna, bacterial - genetics |
3 |
|
enterobacter - enzymology |
3 |
|
enterobacteriaceae - drug effects - genetics |
3 |
|
enterobacteriaceae infections - epidemiology - metabolism |
3 |
|
enzyme inhibitors - pharmacology |
3 |
|
esbls |
3 |
|
escherichia coli - drug effects - enzymology |
3 |
|
escherichia coli - drug effects - enzymology - isolation and purification |
3 |
|
escherichia coli - drug effects - genetics |
3 |
|
escherichia coli - enzymology |
3 |
|
escherichia coli infections - epidemiology - microbiology |
3 |
|
feces |
3 |
|
feces - microbiology |
3 |
|
fluoroquinolones |
3 |
|
hypervirulent |
3 |
|
incompatibility groups |
3 |
|
invasive pneumococcal disease |
3 |
|
klebsiella pneumoniae - drug effects - enzymology |
3 |
|
klebsiella pneumoniae - enzymology - genetics - isolation & purification |
3 |
|
long-term care facilities |
3 |
|
methicillin resistance |
3 |
|
methicillin resistance - genetics |
3 |
|
middle aged |
3 |
|
ndm-1 |
3 |
|
pathogenicity locus |
3 |
|
phylogeny |
3 |
|
pneumococcal conjugate vaccine |
3 |
|
prospective studies |
3 |
|
pulsed-field gel electrophoresis |
3 |
|
renal replacement therapy |
3 |
|
staphylococcal skin infections - epidemiology - microbiology |
3 |
|
staphylococcus aureus - classification - drug effects - isolation & purification |
3 |
|
staphylococcus lugdunensis |
3 |
|
trehalose repressor |
3 |
|
vibrio cholerae - genetics - metabolism |
3 |
|
acinetobacter baumannii |
2 |
|
acinetobacter baumannii - classification - drug effects - isolation & purification |
2 |
|
acinetobacter baumannii - drug effects |
2 |
|
acinetobacter infections - epidemiology - microbiology |
2 |
|
adolescent |
2 |
|
aminoglycoside resistance |
2 |
|
anti-bacterial agents - chemical synthesis - pharmacology |
2 |
|
anti-bacterial agents - chemistry |
2 |
|
anti-bacterial agents - chemistry - pharmacology |
2 |
|
anti-infective agents - pharmacology - therapeutic use |
2 |
|
antimicrobial resistance epidemiology |
2 |
|
bacteraemia |
2 |
|
bacterial capsules |
2 |
|
bacterial contamination |
2 |
|
bacterial proteins - metabolism |
2 |
|
bacterial toxins - genetics |
2 |
|
bacterial typing techniques |
2 |
|
bacteroides |
2 |
|
bacteroides dorei |
2 |
|
bacteroides fragilis |
2 |
|
bacteroides thetaoiotaomicron |
2 |
|
beta-lactamases - chemistry |
2 |
|
beta-lactamases - classification - genetics - metabolism |
2 |
|
beta-lactamases - metabolism |
2 |
|
beta-lactamases - secretion |
2 |
|
binding, competitive |
2 |
|
blood donation |
2 |
|
bloodstream infections |
2 |
|
calorimetry, differential scanning |
2 |
|
carbapenem resistance |
2 |
|
carbapenems |
2 |
|
carbuncle - microbiology |
2 |
|
catalysis |
2 |
|
cefotaxime resistance |
2 |
|
cefoxitin |
2 |
|
chlorhexidine |
2 |
|
circular dichroism |
2 |
|
community-acquired infections |
2 |
|
community-acquired infections - epidemiology - microbiology |
2 |
|
community-acquired infections - microbiology |
2 |
|
ctx-m beta-lactamase |
2 |
|
dimerization |
2 |
|
disease outbreaks - history |
2 |
|
dna fingerprinting - methods |
2 |
|
drug resistance, microbial - genetics |
2 |
|
drug resistance, multiple |
2 |
|
e. coli |
2 |
|
enterobacteriaceae - drug effects - enzymology |
2 |
|
enterococcus - drug effects |
2 |
|
escherichia coli - classification - drug effects - genetics - isolation & purification |
2 |
|
escherichia coli - drug effects - enzymology - genetics - isolation & purification |
2 |
|
escherichia coli - enzymology - isolation & purification |
2 |
|
escherichia coli proteins - genetics |
2 |
|
escherichia coli proteins - genetics - metabolism |
2 |
|
exotoxins - genetics |
2 |
|
fluoroquinolone resistance |
2 |
|
fosfomycin resistance |
2 |
|
gene cassettes |
2 |
|
genes, bacterial - genetics |
2 |
|
glycopeptides |
2 |
|
h. influenzae |
2 |
|
haemophilus infections - epidemiology - microbiology |
2 |
|
health facilities |
2 |
|
history, 20th century |
2 |
|
hydrogel - chemical synthesis - chemistry |
2 |
|
hydrogels - chemistry |
2 |
|
hydrogen bonding |
2 |
|
imipenem - pharmacology |
2 |
|
imipenem resistance |
2 |
|
incidence |
2 |
|
influenza |
2 |
|
influenza, human - epidemiology - history - mortality |
2 |
|
integrons |
2 |
|
klebsiella pneumoniae |
2 |
|
klebsiella pneumoniae - drug effects - genetics - isolation & purification |
2 |
|
leukocidins - genetics |
2 |
|
lincosamides - pharmacology |
2 |
|
macrolides - pharmacology |
2 |
|
macromolecular substances - chemical synthesis - chemistry |
2 |
|
magnetic resonance spectroscopy |
2 |
|
media |
2 |
|
methicillin |
2 |
|
methicillin - pharmacology |
2 |
|
methicillin resistance - drug effects - genetics |
2 |
|
methicillin resistance and meca gene |
2 |
|
methicillin-resistant staphylococcus aureus - classification - genetics - isolation & purification |
2 |
|
metronidazole resistance |
2 |
|
microscopy, electron |
2 |
|
models, molecular |
2 |
|
molecular conformation |
2 |
|
mortality |
2 |
|
multidrug resistance |
2 |
|
organoplatinum compounds - chemical synthesis - pharmacology |
2 |
|
oxacillin agar screening method |
2 |
|
oxacillin resistance |
2 |
|
pandemic |
2 |
|
panton-valentine leukocidin |
2 |
|
phenotype |
2 |
|
pneumococcal infections - drug therapy - microbiology |
2 |
|
pneumonia, pneumococcal - epidemiology - microbiology |
2 |
|
population surveillance |
2 |
|
pyrenes - chemistry |
2 |
|
resistance plasmid |
2 |
|
retrospective studies |
2 |
|
risk |
2 |
|
s. aureus |
2 |
|
sccmec |
2 |
|
selective medium |
2 |
|
skin disinfection |
2 |
|
spectrometry, fluorescence |
2 |
|
spectrometry, mass, electrospray ionization |
2 |
|
staphylococcal protein a - genetics |
2 |
|
staphylococci |
2 |
|
staphylococcus aureus - drug effects |
2 |
|
staphylococcus aureus - drug effects - genetics - isolation & purification |
2 |
|
streptococcus pneumoniae - drug effects - isolation & purification |
2 |
|
streptogramins - pharmacology |
2 |
|
structure-activity relationship |
2 |
|
sulfamethoxazole - pharmacology |
2 |
|
susceptibility test comparison |
2 |
|
terminology as topic |
2 |
|
thermodynamics |
2 |
|
trans-activators - genetics |
2 |
|
trimethoprim - pharmacology |
2 |
|
urinary tract infections |
2 |
|
urinary tract infections - epidemiology - microbiology |
2 |
|
urine - microbiology |
2 |
|
vancomycin - analogs & derivatives - chemical synthesis - pharmacology |
2 |
|
vancomycin - analogs & derivatives - chemistry |
2 |
|
vancomycin - analogs & derivatives - chemistry - pharmacology |
2 |
|
water - chemistry |
2 |
|
wound infection - epidemiology - microbiology |
2 |
|
x-ray diffraction |
2 |
|
young adult |
2 |
